Vicki Nienaber-Meadows, PhD has over 30 years' experience at large companies, mid-sized biotech and her own small biotech. Throughout her career, she has been both an early adopter, as well as an inventor of instrumentation and technology directed towards early-stage drug discovery. She has overseen large multi-national drug discovery programs, early-stage drug discovery pipelines and built platforms consisting of robotics, procedures and relational databases and two companies.
President and CSO, Zenobia Therapeutics Inc.
Former CSO, ActiveSight (A Rigaku Company)
Former Senior Director of Lead Discovery, Alliance Management and Crystallography, SGX Pharmaceuticals
Former Senior Scientist and Project Manager, Abbott Laboratories